These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10899410)

  • 41. Deletion of the parkin and PACRG gene promoter in early-onset parkinsonism.
    Lesage S; Magali P; Lohmann E; Lacomblez L; Teive H; Janin S; Cousin PY; Dürr A; Brice A;
    Hum Mutat; 2007 Jan; 28(1):27-32. PubMed ID: 17068781
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A consanguineous Turkish family with early-onset Parkinson's disease and an exon 4 parkin deletion.
    Dogu O; Johnson J; Hernandez D; Hanson M; Hardy J; Apaydin H; Özekmekçi S; Sevim S; Gwinn-Hardy K; Singleton A
    Mov Disord; 2004 Jul; 19(7):812-816. PubMed ID: 15254940
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Parkin mutations are frequent in patients with isolated early-onset parkinsonism.
    Periquet M; Latouche M; Lohmann E; Rawal N; De Michele G; Ricard S; Teive H; Fraix V; Vidailhet M; Nicholl D; Barone P; Wood NW; Raskin S; Deleuze JF; Agid Y; Dürr A; Brice A; ;
    Brain; 2003 Jun; 126(Pt 6):1271-8. PubMed ID: 12764050
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Parkin mutations and susceptibility alleles in late-onset Parkinson's disease.
    Oliveira SA; Scott WK; Martin ER; Nance MA; Watts RL; Hubble JP; Koller WC; Pahwa R; Stern MB; Hiner BC; Ondo WG; Allen FH; Scott BL; Goetz CG; Small GW; Mastaglia F; Stajich JM; Zhang F; Booze MW; Winn MP; Middleton LT; Haines JL; Pericak-Vance MA; Vance JM
    Ann Neurol; 2003 May; 53(5):624-9. PubMed ID: 12730996
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The striatal dopaminergic deficit is dependent on the number of mutant alleles in a family with mutations in the parkin gene: evidence for enzymatic parkin function in humans.
    Hilker R; Klein C; Hedrich K; Ozelius LJ; Vieregge P; Herholz K; Pramstaller PP; Heiss WD
    Neurosci Lett; 2002 Apr; 323(1):50-4. PubMed ID: 11911988
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association between early-onset Parkinson's disease and mutations in the parkin gene.
    Lücking CB; Dürr A; Bonifati V; Vaughan J; De Michele G; Gasser T; Harhangi BS; Meco G; Denèfle P; Wood NW; Agid Y; Brice A; ;
    N Engl J Med; 2000 May; 342(21):1560-7. PubMed ID: 10824074
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Levodopa-responsive dystonia. GTP cyclohydrolase I or parkin mutations?
    Tassin J; Dürr A; Bonnet AM; Gil R; Vidailhet M; Lücking CB; Goas JY; Durif F; Abada M; Echenne B; Motte J; Lagueny A; Lacomblez L; Jedynak P; Bartholomé B; Agid Y; Brice A
    Brain; 2000 Jun; 123 ( Pt 6)():1112-21. PubMed ID: 10825351
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New mutation (R42P) of the parkin gene in the ubiquitinlike domain associated with parkinsonism.
    Terreni L; Calabrese E; Calella AM; Forloni G; Mariani C
    Neurology; 2001 Feb; 56(4):463-6. PubMed ID: 11222788
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of alpha-synuclein, parkin, tau, and UCH-L1 in a Japanese family with autosomal dominant parkinsonism.
    Hasegawa K; Funayama M; Matsuura N; Furusawa H; Sakai F; Kowa H; Obata F
    Eur Neurol; 2001; 46(1):20-4. PubMed ID: 11455179
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of codon 167 Ser/Asn heterozygosity in the parkin gene with sporadic Parkinson's disease.
    Satoh J; Kuroda Y
    Neuroreport; 1999 Sep; 10(13):2735-9. PubMed ID: 10511432
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27.
    Cesari R; Martin ES; Calin GA; Pentimalli F; Bichi R; McAdams H; Trapasso F; Drusco A; Shimizu M; Masciullo V; D'Andrilli G; Scambia G; Picchio MC; Alder H; Godwin AK; Croce CM
    Proc Natl Acad Sci U S A; 2003 May; 100(10):5956-61. PubMed ID: 12719539
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Parkin gene and its function; a key to understand nigral degeneration].
    Hattori N; Mizuno Y
    Rinsho Shinkeigaku; 1999 Dec; 39(12):1259-61. PubMed ID: 10791092
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mutation screening and association analysis of the parkin gene in Parkinson's disease patients from South-West China.
    Peng R; Gou Y; Yuan Q; Li T; Latsoudis H; Yuan G; Luo D; Liu X; Collier DA
    Eur Neurol; 2003; 49(2):85-9. PubMed ID: 12584415
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Camptocormia, axial dystonia, and parkinsonism: phenotypic heterogeneity of a parkin mutation.
    Inzelberg R; Hattori N; Nisipeanu P; Abo Mouch S; Blumen SC; Carasso RL; Mizuno Y
    Neurology; 2003 Apr; 60(8):1393-4. PubMed ID: 12707457
    [No Abstract]   [Full Text] [Related]  

  • 55. A family with Parkinson disease, essential tremor, bell palsy, and parkin mutations.
    Deng H; Le WD; Hunter CB; Mejia N; Xie WJ; Jankovic J
    Arch Neurol; 2007 Mar; 64(3):421-4. PubMed ID: 17353387
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Homozygous deletion mutation of the parkin gene in patients with atypical parkinsonism.
    Kuroda Y; Mitsui T; Akaike M; Azuma H; Matsumoto T
    J Neurol Neurosurg Psychiatry; 2001 Aug; 71(2):231-4. PubMed ID: 11459900
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutation of the Parkin gene in a Persian family: clinical progression over a 40-year period.
    Clarimon J; Johnson J; Djaldetti R; Hernandez D; Hattori N; Sroka H; Barhom Y; Singleton A
    Mov Disord; 2005 Jul; 20(7):887-90. PubMed ID: 15852366
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A molecular explanation for the recessive nature of parkin-linked Parkinson's disease.
    Spratt DE; Martinez-Torres RJ; Noh YJ; Mercier P; Manczyk N; Barber KR; Aguirre JD; Burchell L; Purkiss A; Walden H; Shaw GS
    Nat Commun; 2013; 4():1983. PubMed ID: 23770917
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heterogeneous phenotype in a family with compound heterozygous parkin gene mutations.
    Deng H; Le WD; Hunter CB; Ondo WG; Guo Y; Xie WJ; Jankovic J
    Arch Neurol; 2006 Feb; 63(2):273-7. PubMed ID: 16476817
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of compound heterozygous deletions in the parkin gene of fibroblasts in patients with autosomal recessive hereditary parkinsonism (PARK2).
    Nakaso K; Adachi Y; Yasui K; Sakuma K; Nakashima K
    Neurosci Lett; 2006 May; 400(1-2):44-7. PubMed ID: 16517073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.